December 11, 2024

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

October 15, 2024

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

August 1, 2024

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

November 15, 2023

Press Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023

ECOG-ACRIN Cancer Research Group